Olanzapine in the treatment of adolescents with anorexia nervosa;Olanzapine in de behandeling van adolescenten met anorexia nervosa

Tijdschrift voor Psychiatrie

Volumn 52, Issue 6, 2010, Pages 417-421

  Hein, I M ^a   Huyser, C ^a  

^a De Bascule   (Netherlands)

Author keywords

Adolescent; Anorexia nervosa; Olanzapine

Indexed keywords

OLANZAPINE;

ADOLESCENT; ANOREXIA NERVOSA; ARTICLE; CASE REPORT; CLINICAL TRIAL; DRUG MONITORING; FEMALE; HUMAN; TREATMENT RESPONSE;

ADOLESCENT; ANOREXIA NERVOSA; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; TREATMENT OUTCOME;

EID: 77953741711     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Batbarich, N.C., McConaha, C.W., Gaskill, J., e.a. (2004). An open trial of olanzapine in anorexia nervosa. Journal of clinical Psychiatry, 65, 1480-1482.
2. Bissada, H., Tasca, G.A., Barber, A.M., e.a. (2008). Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial. The American Journal of Psychiatry, 165, 1281-1288.
3. Brambilla, F, Garcia, C.S., Fassino, S., e.a. (2007). Olanzapine therapy in anorexia nervosa: psychobiological effects. International Clinical Psychopharmacology, 22, 197-204.
4. Bosanac, P., Norman, T., Burrows, G., e.a. (2005). Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics? Australian and New Zealand Journal of Psychiatry, 39, 146-153.
5. Bosanac, P., Kurlander, S., Norman, T., e.a (2007). An open-label study of quetiapine in anorexia nervosa. Human Psychopharmacology: Clinical and Experimental, 22, 223-230.
6. Claudino, A.M., de Lima, M.S., Hay, P., e.a. (2009a). Antidepressants for anorexia nervosa (Review). The Cochrane Database of Systematic Reviews, 1, CD004365.
7. Claudino, A.M., Hay, P., de Lima, M.S., e.a. (2009b). Antipsychotic drugs for anorexia nervosa (Protocol). The Cochrane Database of Systematic Reviews, 1, CD006816.
8. Gowers, S.G., (2008). Management of eating disorders in children and adolescents. Archives of Disease in Childhood, 93, 331-334. (Pubitemid 352025835)
9. Halmi, K.A., (2008). The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients. The American Journal of Psychiatry, 165, 1227-1228.
10. Landelijke Stuurgroep Multidisciplinaire richtlijnontwikkeling in de GGZ (2006). Multidisciplinaire richtlijn eetstoornissen, diagnostiek en behandeling van eetstoornissen. Utrecht: Trimbos-instituut.
11. Malina, A., Gas kill, J., McCohana, C., e.a. (2003). Olanzapine treatment of anorexia nervosa: a retrospective study. International Journal of Eating Disorders, 33, 234-237.
12. Mehler-Wex, C., Romanos, M., Kirchheiner, J., e.a. (2008). Atypical antipsychotics in severe anorexia nervosa in children and adolescents - Review and case reports. European Eating Disorders Review, 16, 100-108.
13. Powers, P.S., Bannon, Y., Eubanks, R., e.a. (2007). Quetiapine in anorexia nervosa patients: an open label outpatient pilot study. International Journal of Eating Disorders, 40, 21-26.
14. Powers, P.S., Santana, C.A., & Bannon, Y.S. (2002). Olanzapine in the treatment of anorexia nervosa: An open label trial. International Journal of Eating Disorders, 32, 146-154.
15. Spettigue, W., Buchholz, A., Henderson, K., e.a. (2008). Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial. BMC Pediatrics, 8, 4.
16. Wentz, E., Gilberg, I.G., Anckersäter, H., e.a. (2009). Adolescent-onset anorexia nervosa: 18-year outcome. The British Journal of Psychiatry, 194, 168-174.